Iplimma

Related products

• 

  Hodgkin's disease , Multiple myeloma

  Methyl benzamidine

  【Product name】MATULANE

  [English common name]Procarbazine

  [Chinese common name]Methyl benzamidine

  [English name]

  [Chinese other name]

  [indications]
  1. Hodgkin's disease: can make 1/3 to 1/2 patients completely relieved, andNitrogen mustard,VincristineThe MOPP program consisting of prednisone is one of the basic programs for the treatment of Hodgkin's disease.
  2. RightHodgkin's lymphomaMalignant histiocytosis (malignant histiocytosis), mycosis fungoides (sputum granuloma),Multiple myeloma,Melanoma,Brain tumorEtc. also has a certain effect.
  3. In combination with radiotherapy, treatment shows a beneficial effect on radiation-resistant bronchial adenocarcinoma.

  【Dosage】
  1. Oral: 150 to 300 mg per day, divided into 3 to 4 times, or 150 to 200 mg before bedtime, even for 2 weeks, repeated after 4 weeks, the total dose of one course depends on the blood, usually 7 ~ 9g . When the MOPP regimen is used to treat Hodgkin's disease, it is 100 mg/m2 per day for 14 days.
  2. Intravenous infusion: 2 ~ 7mg / kg, gradually increased from the lower dose, a total of 7 ~ 10g a course of treatment.

  [Storage]Store at room temperature, sealed, and protected from light.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Non-small cell lung cancer (NSCLC) , Melanoma

  nivolumab

  【Product name】Opdivo, pdivo

  [English common name]Nivolumab

  [Chinese common name]nivolumab

  [English name]Nye VOL ue mab

  [Chinese other name]Niluzumab

  [indications] can not be removed or transferredMelanoma
  OPDIVO (nivolumab) Navuzumab is indicated for the treatment of disease progression in patients with unremovable or metastatic melanoma and Iplimum and, such as BRAF V600 mutation-positive, a BRAF inhibitor.
  This indication is approved under accelerated approval based on the tumor response rate and the persistence of the response. The continuation of this indication may depend on the validation and description of the clinical benefit in the validation trial.
  Metastatic squamous non-small cell lung cancer
  OPDIVO (nivolumab) Nawu monoclonal antibody is suitable for metastasisNon-small cell lung cancer (NSCLC)Treatment with platinum-based chemotherapy or post-transfer patients.

  【Dosage】The recommended dose of OPDIVO is 3 mg/kg administered intravenously for 60 minutes every 2 weeks until disease progression or unacceptable toxicity.

  [Storage]Store OPDIVO in a refrigerator at 2 ° C to 8 ° C (36 ° F - 46 ° F). Protect OPDIVO Nawu mAb in the original package before use. Do not freeze or shake.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer , Myelodysplastic syndrome

  Azacitidine

  【Product name】VIDAZA 

  [English common name]Azacitidine

  [Chinese common name]Azacitidine

  [English name]

  [Chinese other name]

  [indications]Acute non-lymphocytic leukemia. Used forBreast cancer,Intestinal cancer,MelanomaWait for a certain effect.

  [Usage and dosage] 100mg/m2, intravenous bolus injection, once every 8 hours, for 5 days, 200mg / (m2 · d) intravenous infusion, for 5 days.

  [Storage] Vidaza should be re-injected with water. The shelf life of the reconstituted drug can be extended by reinjection with frozen (2 ° C to 8 ° C) water.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Melanoma

  dabrafenib

  【Product name】Tafinlar

  [English common name]Dabrafenib

  [Chinese common name]dabrafenib

  [English name]

  [Chinese other name]

  [indications]
  1. Unremovable or transferred BRAF V600E gene mutantMelanoma(Not applicable to BRAF wild type melanoma).
  2. In combination with trimetiridine for the treatment of patients with unremovable or metastatic melanoma with BRAF V600E or V600K mutations.

  【Dosage】150 mg, orally, twice daily (12 hours apart), continued administration until disease progression or intolerable toxicity.
  1. Take 1 hour before meals or 2 hours after meals
  2. The lost dose can be taken 6 hours before the next dose, not within 6 hours from the next dose.
  3. Do not open, crush, or break the capsule

  [Storage] Store at 25 ° C (77 ° F); Allow 15 ° C to 30 ° C (59 ° F to 86 ° F)

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.